OrSense

Noninvasive Measurement of Blood Parameters

Health Tech & Life Sciences
Active
Mature Petah Tikva Founded 1996
Total raised
$44.4M
Last: Series E 2011-05
Stage
Mature
Founded
1996
Headcount
23
HQ
Petah Tikva
Sector
Health Tech & Life Sciences

About

OrSense is a medical device company that develops and commercializes noninvasive monitoring technologies for continuous and spot measurements of hemoglobin, oxygen saturation, glucose, and other blood parameters.

The companys patented SpectOLight technology, known as occlusion spectroscopy, uses a non-invasive optical measurement platform combined with a finger-attached, ring-shaped sensor probe. The pressure applied by the sensor temporarily occludes the blood flow in the finger, creating new blood dynamics that generate a unique, strong optical signal, yielding a high signal-to-noise ratio that is wholly blood specific. Analysis of the signal provides the sensitivity necessary to measure hemoglobin, pulse rate, oxymetry (even under severe low perfusion levels), and other analyte concentrations.

Funding history · 5 rounds · $44.4M total

2011-05
Series E $18.0M
2006-02
Series D $6.0M
2004-02
Series C $7.0M
2001-08
Series B $8.2M
Date unknown
Series A $4.0M

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Monitors
Technologies
SensingOpticPlatforms & InterfacesSoftware
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 Patents

Tags

spectroscopysensorsmeasurementsdiabetesmonitoringhospitalsmedical-devicesnon-invasivehealthcare-providerssoftware-applicationsoptronicsmedical-technologies